Sera from four patients who developed both skin toxicity and colitis/diarrhea also showed increased autoantibodies to tubulins (TUBB2A, TUBB4A, TUBB, TUBB4B) on treatment. This evidence concerns the gene TUBB4B and dermatological toxicity.